293 related articles for article (PubMed ID: 23463074)
21. Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.
Wang R; Liu W; Helfer CM; Bradner JE; Hornick JL; Janicki SM; French CA; You J
Cancer Res; 2014 Jun; 74(12):3332-43. PubMed ID: 24736545
[TBL] [Abstract][Full Text] [Related]
22. NUT midline carcinoma: an aggressive intrathoracic neoplasm.
Parikh SA; French CA; Costello BA; Marks RS; Dronca RS; Nerby CL; Roden AC; Peddareddigari VG; Hilton J; Shapiro GI; Molina JR
J Thorac Oncol; 2013 Oct; 8(10):1335-8. PubMed ID: 24457244
[TBL] [Abstract][Full Text] [Related]
23. Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases.
Giridhar P; Mallick S; Kashyap L; Rath GK
Eur Arch Otorhinolaryngol; 2018 Mar; 275(3):815-821. PubMed ID: 29356890
[TBL] [Abstract][Full Text] [Related]
24. Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma.
Yan J; Diaz J; Jiao J; Wang R; You J
J Biol Chem; 2011 Aug; 286(31):27663-75. PubMed ID: 21652721
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.
Haack H; Johnson LA; Fry CJ; Crosby K; Polakiewicz RD; Stelow EB; Hong SM; Schwartz BE; Cameron MJ; Rubin MA; Chang MC; Aster JC; French CA
Am J Surg Pathol; 2009 Jul; 33(7):984-91. PubMed ID: 19363441
[TBL] [Abstract][Full Text] [Related]
26. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
[TBL] [Abstract][Full Text] [Related]
27. A 47-year-old woman with nuclear protein in testis midline carcinoma masquerading as a sinus infection: a case report and review of the literature.
Elkhatib SK; Neilsen BK; Sleightholm RL; Baine MJ; Zhen W
J Med Case Rep; 2019 Mar; 13(1):57. PubMed ID: 30853030
[TBL] [Abstract][Full Text] [Related]
28. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.
Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA
Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114
[TBL] [Abstract][Full Text] [Related]
29. A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.
Suzuki S; Kurabe N; Minato H; Ohkubo A; Ohnishi I; Tanioka F; Sugimura H
Pathol Res Pract; 2014 Jun; 210(6):383-8. PubMed ID: 24655834
[TBL] [Abstract][Full Text] [Related]
30. NUT midline carcinoma presenting with bilateral ovarian metastases: a case report.
Dragoescu E; French C; Cassano A; Baker S; Chafe W
Int J Gynecol Pathol; 2015 Mar; 34(2):136-42. PubMed ID: 25675182
[TBL] [Abstract][Full Text] [Related]
31. Cytologic findings of NUT midline carcinoma in the hilum of the lung.
Policarpio-Nicolas ML; de Leon EM; Jagirdar J
Diagn Cytopathol; 2015 Sep; 43(9):739-42. PubMed ID: 26138851
[TBL] [Abstract][Full Text] [Related]
32. NUT midline carcinoma of the head and neck: current perspectives.
Napolitano M; Venturelli M; Molinaro E; Toss A
Onco Targets Ther; 2019; 12():3235-3244. PubMed ID: 31118674
[No Abstract] [Full Text] [Related]
33. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
[TBL] [Abstract][Full Text] [Related]
34. HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report.
Esteves G; Ferreira J; Afonso R; Martins C; Zagalo C; Félix A
Head Neck Pathol; 2020 Dec; 14(4):1117-1122. PubMed ID: 31989434
[TBL] [Abstract][Full Text] [Related]
35. A case of endobronchial NUT midline carcinoma with intraluminal growth.
Watanabe S; Hirano S; Mine S; Yoshida A; Motoi T; Ishii S; Naka G; Takeda Y; Igari T; Sugiyama H; Kobayashi N
Anticancer Res; 2015 Mar; 35(3):1607-12. PubMed ID: 25750317
[TBL] [Abstract][Full Text] [Related]
36. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.
Fang W; French CA; Cameron MJ; Han Y; Liu H
Int J Surg Pathol; 2013 Apr; 21(2):102-10. PubMed ID: 22777717
[TBL] [Abstract][Full Text] [Related]
38. NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary.
Shehata BM; Steelman CK; Abramowsky CR; Olson TA; French CA; Saxe DF; Ricketts RR; Katzenstein HM
Pediatr Dev Pathol; 2010; 13(6):481-5. PubMed ID: 20017639
[TBL] [Abstract][Full Text] [Related]
39. NUT midline carcinoma in the right orbit: a case report.
Ding T; Wang Y; Zhao T; Xu Z; Gao W; Cui Z; Du Y
Cancer Biol Ther; 2019; 20(8):1091-1096. PubMed ID: 30991882
[TBL] [Abstract][Full Text] [Related]
40. Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is.
Liao S; Maertens O; Cichowski K; Elledge SJ
Genes Dev; 2018 Sep; 32(17-18):1188-1200. PubMed ID: 30135075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
